Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
about
Distinct roles for intra- and extracellular siderophores during Aspergillus fumigatus infectionSiderophore biosynthesis but not reductive iron assimilation is essential for Aspergillus fumigatus virulenceAspergillus fumigatus triggers inflammatory responses by stage-specific beta-glucan displayThe beta-glucan receptor dectin-1 recognizes specific morphologies of Aspergillus fumigatusPneumonia in the neutropenic cancer patientSreA-mediated iron regulation in Aspergillus fumigatusTreatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialInvasive aspergillosis in the intensive care unitAspergillus genomes and the Aspergillus cloudIdentification and analysis of cation channel homologues in human pathogenic fungiComprehensive spectroscopic, steady state, and transient kinetic studies of a representative siderophore-associated flavin monooxygenaseIdentification of a putative Crf splice variant and generation of recombinant antibodies for the specific detection of Aspergillus fumigatusIdentification and comparative analysis of sixteen fungal peptidyl-prolyl cis/trans isomerase repertoires.CADRE: the Central Aspergillus Data REpositoryPolyphasic taxonomy of Aspergillus section Fumigati and its teleomorph NeosartoryaConidiation color mutants of Aspergillus fumigatus are highly pathogenic to the heterologous insect host Galleria mellonella.Fungal infections in transplant and oncology patients.Embryonated eggs as an alternative infection model to investigate Aspergillus fumigatus virulence.Evaluation of lysine biosynthesis as an antifungal drug target: biochemical characterization of Aspergillus fumigatus homocitrate synthase and virulence studiesLarvicidal activity of isolated compound 5-(2,4-dimethylbenzyl) pyrrolidin-2-one from marine Streptomyces VITSVK5 sp. against Rhipicephalus (Boophilus) microplus, Anopheles stephensi, and Culex tritaeniorhynchus.CADRE: the Central Aspergillus Data REpository 2012Aspergillus fumigatus inhibits angiogenesis through the production of gliotoxin and other secondary metabolites.Regulatory interactions for iron homeostasis in Aspergillus fumigatus inferred by a Systems Biology approachFungal infection of the colonMultidimensional volumetric imaging of pulmonary infiltrates for measuring therapeutic response to antifungal therapy in experimental invasive pulmonary aspergillosis.The small GTPase RacA mediates intracellular reactive oxygen species production, polarized growth, and virulence in the human fungal pathogen Aspergillus fumigatus.Polyphasic identification and susceptibility to seven antifungals of 102 Aspergillus isolates recovered from immunocompromised hosts in Greece.Epidemiology of invasive fungal infections in the mediterranean areaAspergillus fumigatus and related species.Posaconazole prophylaxis in experimental azole-resistant invasive pulmonary aspergillosis.Pharmacodynamics of isavuconazole in an Aspergillus fumigatus mouse infection modelThe proteomic signature of Aspergillus fumigatus during early development.Invasive aspergillosis in patients with hematologic malignancies.Pharmacodynamic effects of simulated standard doses of antifungal drugs against Aspergillus species in a new in vitro pharmacokinetic/pharmacodynamic modelThe Dynamic Genome and Transcriptome of the Human Fungal Pathogen Blastomyces and Close Relative EmmonsiaConcentration-dependent synergy and antagonism within a triple antifungal drug combination against Aspergillus species: analysis by a new response surface model.Aspergillus fumigatus MedA governs adherence, host cell interactions and virulencePolarized response of endothelial cells to invasion by Aspergillus fumigatus.Role of laeA in the Regulation of alb1, gliP, Conidial Morphology, and Virulence in Aspergillus fumigatus.Use of bronchoalveolar lavage to detect galactomannan for diagnosis of pulmonary aspergillosis among nonimmunocompromised hosts.
P2860
Q21559506-707320D8-7E85-42ED-9AB3-721FBC2B72A2Q24647631-5468AE9A-9AA8-4261-9541-085D3A72F3B9Q24811085-6A19A37D-0B31-405E-B1F4-F41EBB81D767Q24811208-8F213A47-A93D-4EC5-B983-CB4A37530E9CQ26827758-BF8F8FB2-BD2D-4E94-8AF5-13E291BC3281Q27976506-A66D0BA4-A484-4CFC-B603-3812BA562FBBQ28277029-050FE8B6-34E8-4B33-A32F-297E7F8A0FB6Q28306909-F7ED55A2-3AC8-4EDD-8933-5FD2B78A720EQ28388903-63F48499-D92B-4D3A-AFA3-2130F6776CB9Q28481844-DEBC16C3-3D50-4077-87AC-BD7F093B1DE7Q28492524-1AB1E3E0-1720-418B-8AF2-A9B37186F7BDQ28752041-B6C4905F-BE97-4867-A4FF-753BEE0A6412Q30826128-43194847-FD16-433B-8277-DD030FFF01F1Q30886380-AC7E0592-C8B9-4049-ACA5-75CA6565528EQ33336072-369E26F6-62DE-4BFE-B0D7-9E97676ED1DDQ33401237-06C1D2F8-B4BD-4A55-96B6-6548CB25F3BAQ33896940-AE2BA2CC-0CDC-4482-86FF-6EF7974E0AD9Q33963128-1367F7C2-12F7-4EA6-9741-0FEE2BDC35C6Q33983108-13B2B285-F87F-44E6-A795-EC47BDC205BFQ34051089-C5F6791E-2468-41E1-BFCF-C6668428402BQ34073654-E9E50FF1-8CF6-44DC-B99C-F068EDD33F9CQ34078418-B5B56FB6-A425-4D55-B23E-A977A02A862FQ34133098-65902C49-170F-4F7F-A30D-C17BCD6CC4F1Q34415324-D0EA3296-19A8-44B5-8D14-9C5600CBB9A9Q34510443-EBB6042E-2BDD-4254-8EEF-EFACAAAC9058Q34739183-FC96C0F7-5C49-4D44-BDEC-5FAB564549FEQ35005122-C363D762-3ECF-4BDB-9D02-8407DAFDAC83Q35010686-541EC81A-5E2B-4C74-94EF-A20C0F934B40Q35045054-E1F9C8D2-E5D5-4906-A35F-D1BB3D958A50Q35076830-3F436663-D050-4315-BC93-F38D648965E1Q35385554-F711C47A-75C1-45AA-9393-BEA1FDDDDE9EQ35579624-44DD7E3B-D763-4E9F-B1AA-39ADFD64C4CFQ35616161-4EF4E443-7240-45CF-AC18-A3EF328DB1EDQ35666627-8125B0D1-4821-49AE-8C6F-108573D2C493Q35800351-44E7D859-3D22-4938-8AB4-622BF6CE4996Q35840760-589FE40B-CC42-4CFC-8148-625AB8254D2FQ36018377-7AB03800-2A00-4567-AA6E-3F889B801B3AQ36086911-E399E0E8-41AA-478A-8C3B-D7E4185C3E9CQ36095285-C936E48A-D22D-42C9-AD63-50A47FDECD66Q36098515-9E6F2AC6-92FD-4E52-B33B-99D30DAC913F
P2860
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
description
2002 nî lūn-bûn
@nan
2002 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@ast
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@en
type
label
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@ast
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@en
prefLabel
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@ast
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@en
P1476
Aspergillosis. Pathogenesis, clinical manifestations, and therapy.
@en
P2093
Kieren A Marr
Thomas Patterson
P304
875-94, vi
P356
10.1016/S0891-5520(02)00035-1
P577
2002-12-01T00:00:00Z